37.66 +0.02 (0.05%)
After hours: 4:10PM EST
|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||37.50 - 38.31|
|52-week range||23.77 - 72.50|
|PE ratio (TTM)||N/A|
|Earnings date||20 Feb 2017 - 24 Feb 2017|
|Forward dividend & yield||N/A (N/A)|
|1y target est||38.53|
You'll probably be surprised by some of the stock picks from a leading artificial-intelligence system.
Envision Healthcare Corporation today provided preliminary fourth quarter results, announced the date for the release of its financial results for the fourth quarter and full year 2017 and extended the director nomination deadline.
Haeggquist & Eck, LLP, a leading shareholder rights litigation firm, is investigating whether certain directors and officers of Envision Healthcare Corporation breached their fiduciary duties to the Company and its shareholders.
Envision Healthcare Corporation today provided a business and governance update regarding a number of initiatives to execute on its long-term strategy and increase shareholder value.
Envision Healthcare (EVHC), an American healthcare company and national hospital-based physician group, was the top gainer of the S&P 500 on December 27.
Shares of Envision Healthcare (EVHC) rose to the top of the S&P 500 on Wednesday, adding to its gains from last week. Envision Healthcare climbed 82 cents, or 2.4%, to $34.56, while the S&P 500 rose 2.12 ...
Envision Healthcare continues to suffer from low patient volumes, increased leverage, high operating expense and a weak operating environment.
Envision Healthcare, which is an American healthcare company and national hospital-based physician group, was the S&P 500's top gainer on December 21.
Scott+Scott, Attorneys at Law, LLP , a national shareholder and consumer rights litigation firm, is investigating whether certain directors and officers of Envision Healthcare Corporation breached their fiduciary duties to the Company and its shareholders.
Envision Healthcare (EVHC) needs investors to pay close attention to the stock based on moves in the options market lately.
Envision Healthcare (EVHC) has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions as well.
Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Envision Healthcare Corporation breached their fiduciary duties to shareholders.
Envision Healthcare Holdings was the S&P 500's top loser on Wednesday. It opened lower and fell to the lowest levels traded since November 2012.
Shares are plunging after the company whiffed on its earnings report and stated that it is pursuing "strategic alternatives."